Page last updated: 2024-08-25

isoalantolactone and Adenocarcinoma

isoalantolactone has been researched along with Adenocarcinoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Huang, L; Jia, Y; Song, X; Xie, L; Xiong, J; Yao, Y; Ying, S; Yuan, J; Zeng, Z; Zhang, C	1

Other Studies

1 other study(ies) available for isoalantolactone and Adenocarcinoma

Article	Year
Isoalantolactone inhibits pancreatic cancer proliferation by regulation of PI3K and Wnt signal pathway. PloS one, 2021, Volume: 16, Issue:3 Topics: Adenocarcinoma; Animals; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Movement; Cell Proliferation; Humans; Male; Mice, Inbred BALB C; Mice, Nude; Pancreatic Neoplasms; Phosphatidylinositol 3-Kinases; Sesquiterpenes; Wnt Signaling Pathway; Xenograft Model Antitumor Assays	2021

Article

Year

Isoalantolactone inhibits pancreatic cancer proliferation by regulation of PI3K and Wnt signal pathway.

PloS one, 2021, Volume: 16, Issue:3

Topics: Adenocarcinoma; Animals; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Movement; Cell Proliferation; Humans; Male; Mice, Inbred BALB C; Mice, Nude; Pancreatic Neoplasms; Phosphatidylinositol 3-Kinases; Sesquiterpenes; Wnt Signaling Pathway; Xenograft Model Antitumor Assays

2021